When is a new prediction marker useful?: A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk

被引：90

作者：

Greenland, P ^{[1
]}

O'Malley, PG ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2005年 / 165卷 / 21期

关键词：

D O I：

10.1001/archinte.165.21.2454

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2454 / 2456

页数：3

共 14 条

[1] Statins in stroke prevention and carotid atherosclerosis -: Systematic review and up-to-date meta-analysis [J].

Amarenco, P ;

Labreuche, J ;

Lavallée, P ;

Touboul, PJ .

STROKE, 2004, 35 (12) :2902-2909

[2] Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].

Ballantyne, CM ;

Hoogeveen, RC ;

Bang, H ;

Coresh, P ;

Folsom, AR ;

Chambless, LE ;

Myerson, M ;

Wu, KK ;

Sharrett, AR ;

Boerwinkle, E .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (21) :2479-2484

[3] In search of fewer independent risk factors [J].

Brotman, DJ ;

Walker, E ;

Lauer, MS ;

O'Brien, RG .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (02) :138-145

[4] STROKE RISK PROFILE - ADJUSTMENT FOR ANTIHYPERTENSIVE MEDICATION - THE FRAMINGHAM-STUDY [J].

DAGOSTINO, RB ;

WOLF, PA ;

BELANGER, AJ ;

KANNEL, WB .

STROKE, 1994, 25 (01) :40-43

[5] Improving coronary heart disease risk assessment in asymptomatic people - Role of traditional risk factors and noninvasive cardiovascular tests [J].

Greenland, P ;

Smith, SC ;

Grundy, SM .

CIRCULATION, 2001, 104 (15) :1863-1867

[6] Emerging risk factors for atherosclerotic vascular disease - A critical review of the evidence [J].

Hackam, DG ;

Anand, SS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :932-940

[7]

Hawthorne V, 2002, HEART, V88, P222

[8] Judging new markers by their ability to improve predictive accuracy [J].

Kattan, MW .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (09) :634-635

[9]

Lip Gregory Y H, 2004, Clin Evid, P253

[10] Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker [J].

Pepe, MS ;

Janes, H ;

Longton, G ;

Leisenring, W ;

Newcomb, P .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (09) :882-890

← 1 2 →